Prestige Consumer Healthcare Inc (PBH)
70.00
-1.26
(-1.77%)
USD |
NYSE |
May 03, 16:00
70.04
+0.04
(+0.06%)
After-Hours: 20:00
Prestige Consumer Healthcare Cash from Financing (Quarterly): -64.84M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -64.84M |
| September 30, 2023 | -53.55M |
| June 30, 2023 | -54.18M |
| March 31, 2023 | -80.50M |
| December 31, 2022 | -10.02M |
| September 30, 2022 | -47.96M |
| June 30, 2022 | -47.37M |
| March 31, 2022 | -54.12M |
| December 31, 2021 | -67.64M |
| September 30, 2021 | 50.53M |
| June 30, 2021 | 63.65M |
| March 31, 2021 | -83.71M |
| December 31, 2020 | -9.044M |
| September 30, 2020 | -75.30M |
| June 30, 2020 | -111.36M |
| March 31, 2020 | 20.56M |
| December 31, 2019 | -55.68M |
| September 30, 2019 | -47.02M |
| June 30, 2019 | -49.29M |
| March 31, 2019 | -45.00M |
| December 31, 2018 | -53.10M |
| September 30, 2018 | -99.85M |
| June 30, 2018 | -51.38M |
| March 31, 2018 | -64.35M |
| December 31, 2017 | -40.00M |
| Date | Value |
|---|---|
| September 30, 2017 | -54.02M |
| June 30, 2017 | -50.59M |
| March 31, 2017 | 774.45M |
| December 31, 2016 | -65.02M |
| September 30, 2016 | -100.48M |
| June 30, 2016 | -48.00M |
| March 31, 2016 | 165.58M |
| December 31, 2015 | -25.90M |
| September 30, 2015 | -44.72M |
| June 30, 2015 | -42.89M |
| March 31, 2015 | -49.82M |
| December 31, 2014 | -54.13M |
| September 30, 2014 | 711.16M |
| June 30, 2014 | 36.06M |
| March 31, 2014 | -96.70M |
| December 31, 2013 | 42.60M |
| September 30, 2013 | 30.74M |
| June 30, 2013 | -17.80M |
| March 31, 2013 | -30.08M |
| December 31, 2012 | -77.12M |
| September 30, 2012 | -17.00M |
| June 30, 2012 | -27.92M |
| March 31, 2012 | 658.13M |
| December 31, 2011 | -18.00M |
| September 30, 2011 | -16.99M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-111.36M
Minimum
Jun 2020
63.65M
Maximum
Jun 2021
-40.89M
Average
-53.55M
Median
Sep 2023
Cash from Financing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.026M |
| Palatin Technologies Inc | 4.974M |
| iBio Inc | 4.005M |
| Theriva Biologics Inc | -1.457M |
| Oragenics Inc | -0.1806M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 71.47M |
| Cash from Investing (Quarterly) | -4.496M |
| Free Cash Flow | 232.04M |
| Free Cash Flow Per Share (Quarterly) | 1.386 |
| Free Cash Flow to Equity (Quarterly) | 133.11M |
| Free Cash Flow to Firm (Quarterly) | 82.11M |
| Free Cash Flow Yield | 6.62% |